Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)

Abstract Background Targeted lung denervation (TLD) is a bronchoscopically delivered ablation therapy that selectively interrupts pulmonary parasympathetic nerve signaling. The procedure has the potential to alter airway smooth muscle tone and reactivity, decrease mucous secretion, and reduce airway...

Full description

Bibliographic Details
Main Authors: Dirk-Jan Slebos, Bruno Degano, Arschang Valipour, Pallav L. Shah, Gaetan Deslée, Frank C. Sciurba, on behalf of the AIRFLOW-3 Trial Study Group
Format: Article
Language:English
Published: BMC 2020-02-01
Series:BMC Pulmonary Medicine
Subjects:
COPD
Nerves
Targeted lung denervation
Acetylcholine
Anticholinergic
Bronchoscopy
Online Access:https://doi.org/10.1186/s12890-020-1058-5

Internet

https://doi.org/10.1186/s12890-020-1058-5

Similar Items